REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partner Company Update

1 May 2012 07:00

RNS Number : 4213C
Amphion Innovations PLC
01 May 2012
 



 

 

 

Amphion Partner Company, AXCESS, Receives Markman ruling in Savi Litigation

 

 

London and New York, 1 May 2012 - Amphion Innovations plc (LSE: AMP), announces that a Markman ruling was issued in case no. 3:10-cv-01033-F, Axcess International, Inc. (Axcess) vs. Savi Technology, Inc. (Savi) in the United States District Court for the Northern District of Texas, Dallas Division. Also announced is the trial date, now set for November 5, 2012.

 

Amphion Partner Company, Axcess International was issued a patent on September 25, 2001 entitled "High Sensitivity Demodulator for a Radio Tag and Method". The patent discloses a radio tag that uses circuitry capable of demodulating low powered analog carrier signals while drawing minimal current to improve the sensitivity and operational range of the radio tag while maintaining longer battery life. Axcess filed suit against Savi on May 21, 2010 accusing Savi's RFID tags of infringing 23 claims of the patent.

 

A "Markman" hearing is a pretrial hearing in a U.S. District Court during which a judge examines evidence from all parties on the appropriate meanings of relevant key words used in a patent claim, when patent infringement is alleged. Holding a Markman hearing in patent infringement cases has been common practice since the case of Markman v. Westview Instruments, Inc.. It was determined the language of a patent is a matter of law for a judge to decide, not a matter of fact for a jury to decide. Markman hearings are important, since the court determines patent infringement cases by the interpretation of claims.

 

Included in the Order were nine disputed and nine agreed-to claims. The Court construed each of the nine disputed claims in the ruling. The Court also resolved one of the parties' fundamental disputes about the scope of the patent. The Court said that the novelty of the invention was a new and improved tag to receive, process, evaluate, and respond to much weaker signals than such tags were capable of doing before, also increasing the operable life span of the radio tag as well as the distance over which the tag can operate.

 

"Having reached this important milestone, we now look forward to the trial in early November. We encourage interested parties to read the Order", said Allan Griebenow, President & CEO of Axcess International. "Axcess remains fully committed to the protection of this patent and others in our intellectual property portfolio."

 

While Amphion believes the above described ruling can be favorable to Axcess the ruling does not automatically mean that Axcess will prevail at trial. A copy of the Court's ruling can be downloaded from the Company's website at www.axcessinc.com.

 

As a result of additional investment in support of Axcess over the last few years, Amphion Innovations' holdings of equity and warrants now amount to about 14% of the fully diluted outstanding. In addition, Amphion holds approximately $1.8 million of debt, most of which is convertible into common stock.

 

 

 

 

For further information please contact:

 

Amphion Innovations

Charlie Morgan:

+1 (212) 210-6224

 

Cardew Group

Tim Robertson

+44 020 7930 0777

 

Seymour Pierce Limited, Nominated Adviser

Mark Percy/ Freddy Crossley:

+44 020 7107 8300

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has a significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

 

On the web: www.amphionplc.com

 

 

About Axcess International Inc.

Axcess International Inc. (OTCBB: AXSI) provides automated wireless identification solutions for business encompassing local location identification, tracking and control capabilities using its patented MicroWirelessTM technology platform. The complete system solutions supersede existing manual ID systems by automating various tasks that increase productivity, security, safety and business intelligence. MicroWireless - based on active RFID principles - is the economic and technological sweet spot for autonomously-powered low cost, miniature, remote wireless communication devices. Axcess is a portfolio company of Amphion Innovations plc (AIM: AMP). For more information on Axcess, visit www.axcessinc.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAURUWRUKASOAR
Date   Source Headline
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.